Patents by Inventor David Gifford
David Gifford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240122179Abstract: At least some aspects of this disclosure include one or more auxinic herbicides with relatively low volatility. Some of these compounds may be especially useful when used in the process of growing commercially important plants. Methods for using these actives to control the growth and spread of unwanted plants and/or to hasten the growth of desirable plants are also disclosed herein.Type: ApplicationFiled: February 4, 2022Publication date: April 18, 2024Applicant: CORTEVA AGRISCIENCE LLCInventors: DAVID SIMPSON, JEREMY KISTER, MEI LI, BIN WEI, JAMES GIFFORD
-
Patent number: 11464837Abstract: The present disclosure provides for methods, systems, and compositions of nucleic acid and peptide sequences. The present disclosure provides for a nucleic acid sequence encoding two or more amino acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, and SEQ ID NO: 41.Type: GrantFiled: December 15, 2021Date of Patent: October 11, 2022Assignee: Think Therapeutics, Inc.Inventors: David Gifford, Brandon Carter
-
Patent number: 11464842Abstract: Described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 19 to 50. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 141 to 272. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 273 to 322. Also described herein is an immunogenic composition comprising nucleic acid sequences encoding two or more amino acid sequences selected from the group consisting of SEQ ID NOs: 354 to 458.Type: GrantFiled: April 28, 2021Date of Patent: October 11, 2022Assignee: Think Therapeutics, Inc.Inventors: David Gifford, Brandon Carter
-
Patent number: 11421015Abstract: A system for selecting an immunogenic peptide composition comprising a processor and a memory storing processor-executable instructions that, when executed by the processor, cause the processor to create a first peptide set by selecting a plurality of base peptides, wherein at least one peptide of the plurality of base peptides is associated with a disease, create a second peptide set by adding to the first peptide set a modified peptide, wherein the modified peptide comprises a substitution of at least one residue of a base peptide selected from the plurality of base peptides, and create a third peptide set by selecting a subset of the second peptide set, wherein the selected subset of the second peptide set has a predicted vaccine performance, wherein the predicted vaccine performance has a population coverage above a predetermined threshold, and wherein the subset comprises at least one peptide of the second peptide set.Type: GrantFiled: July 30, 2021Date of Patent: August 23, 2022Assignee: Think Therapeutics, Inc.Inventors: David Gifford, Brandon Carter
-
Publication number: 20220213466Abstract: Described herein is a method for determining a lymphocyte cell receptor chain sequence specific to a unique antigen, comprising: sorting a plurality of antigens into a plurality of reaction mixtures, wherein the sorting comprises adding a unique antigen of the plurality of antigens to a unique subset of the plurality of reaction mixtures such that two different unique antigens are not added to the unique subset; contacting each reaction with a biological sample comprising a plurality of lymphocytes; separating a target lymphocyte from a subset of the plurality of lymphocytes, wherein the target lymphocyte recognizes the unique antigen; after separating the target lymphocyte, sequencing nucleic acids of the target lymphocyte to obtain the lymphocyte receptor chain sequence, wherein the sequencing is performed by single-cell sequencing; and detecting the unique antigen, wherein the detecting comprises: computing a frequency of lymphocyte cells that express the lymphocyte receptor chain sequence.Type: ApplicationFiled: July 28, 2021Publication date: July 7, 2022Applicant: Think Therapeutics, Inc.Inventors: David GIFFORD, Brandon CARTER
-
Publication number: 20220177543Abstract: A system for selecting an immunogenic peptide composition comprising a processor and a memory storing processor-executable instructions that, when executed by the processor, cause the processor to create a first peptide set by selecting a plurality of base peptides, wherein at least one peptide of the plurality of base peptides is associated with a disease, create a second peptide set by adding to the first peptide set a modified peptide, wherein the modified peptide comprises a substitution of at least one residue of a base peptide selected from the plurality of base peptides, and create a third peptide set by selecting a subset of the second peptide set, wherein the selected subset of the second peptide set has a predicted vaccine performance, wherein the predicted vaccine performance has a population coverage above a predetermined threshold, and wherein the subset comprises at least one peptide of the second peptide set.Type: ApplicationFiled: July 30, 2021Publication date: June 9, 2022Inventors: David GIFFORD, Brandon CARTER
-
Publication number: 20220160848Abstract: The present disclosure provides for methods, systems, and compositions of nucleic acid and peptide sequences. The present disclosure provides for a nucleic acid sequence encoding two or more amino acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, and SEQ ID NO: 41.Type: ApplicationFiled: December 15, 2021Publication date: May 26, 2022Inventors: David GIFFORD, Brandon CARTER
-
Patent number: 11235039Abstract: The present disclosure provides for methods, systems, and compositions of nucleic acid and peptide sequences. The present disclosure provides for a nucleic acid sequence encoding two or more amino acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, and SEQ ID NO: 41.Type: GrantFiled: June 2, 2021Date of Patent: February 1, 2022Assignee: Think Therapeutics, Inc.Inventors: David Gifford, Brandon Carter
-
Patent number: 11161892Abstract: A system for selecting an immunogenic peptide composition comprising a processor and a memory storing processor-executable instructions that, when executed by the processor, cause the processor to create a first peptide set by selecting a plurality of base peptides, wherein at least one peptide of the plurality of base peptides is associated with a disease, create a second peptide set by adding to the first peptide set a modified peptide, wherein the modified peptide comprises a substitution of at least one residue of a base peptide selected from the plurality of base peptides, and create a third peptide set by selecting a subset of the second peptide set, wherein the selected subset of the second peptide set has a predicted vaccine performance, wherein the predicted vaccine performance has a population coverage above a predetermined threshold, and wherein the subset comprises at least one peptide of the second peptide set.Type: GrantFiled: December 7, 2020Date of Patent: November 2, 2021Assignee: Think Therapeutics, Inc.Inventors: David Gifford, Brandon Carter
-
Patent number: 11111489Abstract: Described herein is a method for determining a lymphocyte cell receptor chain sequence specific to a unique antigen, comprising: sorting a plurality of antigens into a plurality of reaction mixtures, wherein the sorting comprises adding a unique antigen of the plurality of antigens to a unique subset of the plurality of reaction mixtures such that two different unique antigens are not added to the unique subset; contacting each reaction with a biological sample comprising a plurality of lymphocytes; separating a target lymphocyte from a subset of the plurality of lymphocytes, wherein the target lymphocyte recognizes the unique antigen; after separating the target lymphocyte, sequencing nucleic acids of the target lymphocyte to obtain the lymphocyte receptor chain sequence, wherein the sequencing is performed by single-cell sequencing; and detecting the unique antigen, wherein the detecting comprises: computing a frequency of lymphocyte cells that express the lymphocyte receptor chain sequence.Type: GrantFiled: January 6, 2021Date of Patent: September 7, 2021Assignee: Think Therapeutics, Inc.Inventors: David Gifford, Brandon Carter
-
Patent number: 11058751Abstract: The present disclosure provides for methods, systems, and compositions of nucleic acid and peptide sequences. The present disclosure provides for a nucleic acid sequence encoding two or more amino acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 18, SEQ ID NO: 19, SEQ ID NO: 20, SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24, SEQ ID NO: 25, SEQ ID NO: 26, SEQ ID NO: 27, SEQ ID NO: 28, SEQ ID NO: 29, SEQ ID NO: 30, SEQ ID NO: 31, SEQ ID NO: 32, SEQ ID NO: 33, SEQ ID NO: 34, SEQ ID NO: 35, SEQ ID NO: 36, SEQ ID NO: 37, SEQ ID NO: 38, SEQ ID NO: 39, SEQ ID NO: 40, and SEQ ID NO: 41.Type: GrantFiled: November 20, 2020Date of Patent: July 13, 2021Assignee: Think Therapeutics, Inc.Inventors: David Gifford, Brandon Carter
-
Publication number: 20180041484Abstract: In some embodiments, an authentication method comprises receiving a request for a digital signature of data from a delegate computer over a secure channel using cryptography to provide authentication, wherein the secure channel comprises at least one wireless communications link; displaying information derived from the data; prompting a user for approval of the request with information derived from the data; in response to receiving approval from the user, creating the digital signature of the data using one or more private keys stored in a key enclave; and sending the digital signature to the delegate computer over the secure channel.Type: ApplicationFiled: August 3, 2017Publication date: February 8, 2018Applicant: KryptCo, Inc.Inventors: David GIFFORD, Kevin Churan KING, Alex GRINMAN
-
Patent number: 9887975Abstract: In some embodiments, an authentication method comprises receiving a request for a digital signature of data from a delegate computer over a secure channel using cryptography to provide authentication, wherein the secure channel comprises at least one wireless communications link; displaying information derived from the data; prompting a user for approval of the request with information derived from the data; in response to receiving approval from the user, creating the digital signature of the data using one or more private keys stored in a key enclave; and sending the digital signature to the delegate computer over the secure channel.Type: GrantFiled: August 3, 2017Date of Patent: February 6, 2018Assignee: KryptCo, Inc.Inventors: David Gifford, Kevin Churan King, Alex Grinman
-
Publication number: 20070174847Abstract: The invention features various techniques for managing transfers of information in public packet switched communications networks. In one aspect, the invention provides a system for identifying updated items of network-based information, such as pages, to users in a network. A master server receives the data from each of a plurality of network servers and merges them into one or more master logs. The logs have entries that pertaining to creation of or changing of pages of information. Another aspect of the invention features a system for implementing security protocols. A proxy server translates links from a protocol incompatible with the network tool to a protocol compatible with the network tool and back-translates the link. Another aspect of the invention features a system for managing authenticating credentials of a user. A proxy server manages a user's authenticating credentials automatically on behalf of the user.Type: ApplicationFiled: January 4, 2007Publication date: July 26, 2007Applicant: Soverain Software LLCInventors: John Ellis, David Gifford, G. Treese
-
Patent number: 6061424Abstract: Method and apparatus for stereoscopic images using a viewing grid and not requiring a lenticular viewing screen. In one embodiment applied to roentgenography, the apparatus includes an X-ray source, a table or cradle disposed beneath the X-ray source for securing an image subject such as a patient, and a recording medium cassette disposed beneath the table or cradle. The cassette includes a film comprising a base, an emulsion on a first side of the base and a viewing grid on an opposite second side of the base, an image intensifying screen for exposing the emulsion films for recording an image, and a recording grid located between the phosphorous screen and the emulsion side of the film, and fixed in position relative to the image intensifying screen for masking a plurality of strips of predetermined width, of the emulsion film. During exposure, relative movement between the cradle and cassette is maintained so as to capture various views of the image subject on the emulsion film.Type: GrantFiled: October 21, 1996Date of Patent: May 9, 2000Inventors: Reuben Hoppenstein, David Gifford Burder
-
Patent number: 5211088Abstract: A cutting tool having a main body with a longitudinal axis and one or more slide receiving slots. A cutter carrying slide is slidably received within the slide receiving slot in the body for sliding movement relative to the body along a first slide path extending generally normal to the longitudinal axis. A slide positioning member is provided for shifting the cutter carrying slide along the slide path between a retracted position and a cutting position. An anti-backlash device is also provided for establishing and maintaining firm contact between opposing surfaces of the slide and the slide positioning member during movement of the slide toward the cutting position. The anti-backlash device increases force urging the opposing surfaces into contact with each other as radial displacement increases between the slide and an axis of rotation.Type: GrantFiled: October 31, 1991Date of Patent: May 18, 1993Assignee: J. P. Tool, Inc.Inventor: David A. Gifford
-
Patent number: 5086676Abstract: A machine tool and method for simultaneously boring, facing and back boring three bores in a differential carrier with three tools that rotate coaxially with their spindle axes. Each tool has a first slide at its free end that carries a first cutting insert for back boring a first diameter and then generating a radial face that serves as a bearing seat on the differential carrier. Each tool also has a second slide carrying a second insert for boring a second diameter. The construction, arrangement and movement of the two slides are correlated with each other to maintain the tool in balance during extension and retraction of both slides. In the preferred embodiment the first insert must be retracted when it is advanced into the carrier, extended to back bore and then retracted to generate a radial face. The second insert is at the same location circumferentially of the tool. One insert is retracted while the other insert is extended, and vice versa, to maintain the tool in balance.Type: GrantFiled: July 11, 1990Date of Patent: February 11, 1992Assignee: J. P. Tool, Inc.Inventors: David A. Gifford, John L. Taylor